drugset / Trial / NCT04857047
A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This is a randomized, multiple doses, crossover clinical study to compare the pharmacokinetic characteristics and the safety between administration of BR9003 and BR9003A in healthy adult subjects. Within each period, randomized subjects will be taken 2 dosing regimens of administrating BR9003 once a day for six days or BR9003A twice a day for six days.
Timeline
- Start
- 2021-03-31
- Primary completion
- 2021-06-15
- Completion
- 2021-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR9003 | Unknown | 2 mg | Oral |
| Subject | BR9003A | Unknown | 1 mg | Oral |
Indications
No indication recorded.